2 weeks Ago By GuruFocus.com
In This Article: Release Date: February 10, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript . Positive Points Negative Points Q & A Highlights Q : Can you elaborate on pre-launch efforts for JOURNAVX in retail pharmacies and P&T committee review processes? A : Stuart Arbuckle, COO, explained that Vertex has been working with national and regional retail chains to ensure broad availability of JOURNAVX across the U.S.
The product is expected to be with wholesalers by the end of the month and in retail shortly thereafter. Vertex is also working with payers and institutions to provide necessary information for approval processes, including the clinical profile and established price of JOURNAVX..
